Drug · DIN 02361868
OLEPTRO
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since June 30, 2026; first marketed March 9, 2011.
- Drug Identification Number (DIN)
- 02361868
- Company (DIN owner)
- Angelini Pharma IncAtlanta, Georgia, United States
- Schedule
- Prescription
- Dosage form
- Tablet (Extended-Release)
- Route
- Oral
- Therapeutic class (ATC)
- Trazodone N06AX05
- Class
- Human
- Record last updated
- July 17, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| TRAZODONE HYDROCHLORIDE | 150 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- October 31, 2014: NOC 16234New Drug Submission (NDS) · Transfer of drug identification numbers
- January 20, 2012: NOC 12947New Drug Submission (NDS) · Manufacturer name Change
- January 19, 2011: NOC 12013New Drug Submission (NDS)
Other DINs named OLEPTRO
- DIN 02361876 · Cancelled Post Market